Our liquid chromatography and mass spectrometry assays provide precise amino acid sequencing to verify the identity and integrity of your protein candidates.
Creative Biolabs' B cell-based chromatography assay is engineered to deliver a panel of high-quality, target-specific B cells and their corresponding antibody gene sequences with unparalleled speed and efficiency. We provide a clear, direct path from a biological sample to a fully characterized antibody candidate, ready for downstream therapeutic or diagnostic development. This allows you to focus on the science that matters, knowing that your foundational candidates are of the highest quality from day one.
Affinity-based chromatography is a powerful and specific separation method used for bioactive compound isolation and purification employing the binding affinity between immune complexes. Specific monoclonal antibodies or patient immunoglobulin have been used to capture human or mouse tumor tissue-derived antigens, HLA-restricted tumor-specific antigens, and neoantigens. Following the capture process, the proteins bound to the chromatography are eluted and evaluated by various other methods.
To gain a comprehensive understanding of how our services can be applied to your specific research and development needs - Request a consultation.
Fig.1 Immunoaffinity chromatography for protein purification.
| Source of Antibodies | Antibodies Purification Using Chromatography |
|---|---|
|
|
Fig.2 Different formats of antibodies.1,3
| Support Materials | Antibody Conjugation Methods | Elution Conditions |
|---|---|---|
|
|
|
Fig.3 Specific antigen-antibody complex purification using chromatography.2,3
Our chromatography-based method enables the precise isolation of B cells with the highest affinity for your target antigen. This ensures that you obtain the most specific and potent antibody candidates from your initial sample.
The assay platform is built to handle a large volume of B cells from a single sample. This allows for the rapid screening of a vast antibody repertoire, increasing the probability of discovering rare, high-value clones.
By directly isolating antigen-specific B cells, our streamlined workflow bypasses time-consuming and inefficient steps like hybridoma fusion, dramatically accelerating the timeline from sample to gene sequence.
Our efficient, high-throughput process significantly reduces labor and material costs compared to traditional methods. This allows you to achieve a higher success rate with a lower overall investment.
Discover how a partnership with us can streamline your research - Get a quote today.
Using Creative Biolabs' B cell-based chromatography assay in our research has significantly improved the speed of our lead antibody identification. The process is remarkably streamlined, saving us months of development time. - Da Rs.
The assay provided highly specific B cells, eliminating months of frustrating post-screening work and giving us confidence in our candidates from day one. We received a panel of clones that were ready for immediate downstream work. - Ae Mn.
The primary advantage is speed and specificity. Our assay significantly compresses the timeline from immunization to candidate identification. By directly selecting for antigen-specific B cells, we ensure that the candidates you receive have already undergone natural affinity maturation.
Yes. We can isolate B cells that produce a variety of antibody formats, including fragments. As demonstrated in published research, specialized affinity ligands such as Protein L can be effectively used for purifying these fragments, and our upstream assay is perfectly compatible with these downstream purification protocols.
Our liquid chromatography and mass spectrometry assays provide precise amino acid sequencing to verify the identity and integrity of your protein candidates.
We perform immunoprecipitation assays and SDS-PAGE to rigorously test and confirm the purity of your antibody samples before further development.
We offer a range of specificity tests, including Western blot, ELISA, and antibody-mediated cross-blocking assays, to ensure your antibodies bind only to your target antigen.
Utilize advanced techniques like X-ray crystallization, small-angle scattering, and NMR assay to determine the three-dimensional structure of your antibody, providing key insights for optimization.
Creative Biolabs' B cell-based chromatography assay is a transformative solution for the challenges of modern antibody discovery. We deliver the speed, specificity, and cost-effectiveness you need to succeed in a competitive landscape. Our commitment to innovation and deep scientific expertise ensures that your project is in the hands of a trusted partner. Please contact us and consult the service of your interest.
References